RespiGam

Active Ingredient(s): Respiratory Syncytial Virus Immune Globulin, RSV-IGIV
Category: Immune System



RespiGam Overview

Human orthopneumovirus, formerly Human respiratory syncytial virus (HRSV), is a syncytial virus that causes respiratory tract infections. It is a major cause of lower respiratory tract infections and hospital visits during infancy and childhood. A prophylactic medication, palivizumab, can be employed to prevent HRSV in preterm (under 35 weeks gestation) infants, infants with certain congenital heart defects (CHD) or bronchopulmonary dysplasia (BPD), and infants with congenital malformations o...

Read more RespiGam Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Human_respiratory_syncytial_virus

Recent RespiGam Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Respiratory Syncytial Virus Immune Globulin, RSV-IGIV
  • Injection: 50mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain Respiratory Syncytial Virus Immune Globulin, RSV-IGIV or a similar ingredient: (1 result)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 23 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA